NovaResp Technologies provides AI-based medical devices for a respiratory disorder.
NovaResp Technologies has raised $3.0M in total funding. The most recent round was Seed. The last funding was announced in May 2024.
NovaResp Technologies's investors include Concrete Ventures, Center of Aging and Brain Health Innovation, Innovacorp, Invest Nova Scotia, Atlantic Canada Opportunities Agency.
NovaResp Technologies is headquartered in Halifax, Canada.
NovaResp Technologies provides AI-based medical devices for a respiratory disorder.
NovaResp Technologies is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NovaResp Technologies — Funding & Investors." VCBacked, May 14, 2024, https://www.vcbacked.co/company/novaresp-technologies. Accessed July 31, 2026.
VCBacked. (2024). NovaResp Technologies — Funding & Investors. Retrieved July 31, 2026, from https://www.vcbacked.co/company/novaresp-technologies
{{cite web |title=NovaResp Technologies — Funding & Investors |url=https://www.vcbacked.co/company/novaresp-technologies |website=VCBacked |access-date=July 31, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated